Kilitch Drugs India Ltd - 524500 - Board Meeting Outcome for Submission Of Audited Standalone And Consolidated Financial Results For The Quarter Ended 31St March, 2026
Kilitch Drugs' board approved Q4 FY26 audited standalone revenue of ₹71.97 cr (up 27.8% YoY) and net profit of ₹14.00 cr (up 23.1% YoY). Consolidated revenue rose 46.3% to ₹89.60 cr and net profit increased 45.6% to ₹14.88 cr for the quarter. The company also issued 1:1 bonus shares on March 25, 2026.
May 15 2026 19:05:00
Kilitch Drugs India Ltd - 524500 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report
Kilitch Drugs (India) Ltd. reported that ₹1.12 crore from its Rights Issue proceeds, earmarked for capital expenditure, remains unutilized. The deployment, originally scheduled by March 31, 2026, is now expected by Q1FY27 due to a pending final inspection of the greenfield project.
May 15 2026 18:05:00
Kilitch Drugs (India) Limited
KILITCH DRUGS board to meet on May 15, 2026, for Q4 & FY26 results. The meeting will review audited standalone and consolidated financials.
May 07 2026 11:05:00
Kilitch Drugs (India) Limited
Kilitch Drugs (India) Limited announced a board meeting on May 15, 2026. The agenda includes considering and approving the audited standalone and consolidated financial results for the fourth quarter of FY26.
May 07 2026 11:05:00
Kilitch Drugs (India) Limited
Kilitch Drugs (India) Limited announced a board meeting on May 15, 2026. The agenda includes considering and approving the audited standalone and consolidated financial results for the fourth quarter of FY26.
May 07 2026 11:05:00
Kilitch Drugs (India) Limited
Kilitch Drugs (India) Limited announced that its Board of Directors will convene on May 15, 2026. The primary agenda is to consider and approve the audited financial results for the fourth quarter and full financial year ended March 31, 2026.
May 07 2026 11:05:00
Kilitch Drugs India Ltd - 524500 - Board Meeting Intimation for Considering And Approval Of The Audited Financial Results For The Quarter And Year Ended 31St March 2026
Kilitch Drugs' board will convene on May 15, 2026, to approve the company's audited financial results for Q4 FY26 and the full fiscal year ended March 31, 2026.
May 07 2026 11:05:00
Read More